Abstract
AimIn last decades we recognize that the fat tissue isn’t only a depot also an active endocrine tissue. The fat cell isn’t a passive cell, it has an unsteady volume that changes according to daily energy uptake, and releases cytokines and hormones to extracelluler fluid. Patients with type 2 diabetes have distinctly increased atherosclerotic risk. This risk is associated with hyperglycemia, dyslipidemia and increased inflamation. Adiponectine that only secretes from adipose tissue, has a suspected role in this process. In this trial we looked for if there is any effect of adiponectin on glycemic control.MethodsThe patients had been divided in three groups; diabetics with good glycemic control (n:20), diabetics with bad glycemic control (n:34) and non diabetics (n:19). All patients age, sex, history of diabetes, BMI, waist circumference, fat mass, fat % had recorded then serums had taken for adiponectin and HbA1c assesment.ResultsThere was no correlation with adiponectine and HbA1c. Serum adiponectine levels were similar in three groups (659,29 ± 98,57; 694,09 ± 144,85; 609,5 ± 168,24; p:0,117).ConclusionThe results showed that there is no significant effect of adiponectin on glycemic control contrary to expectations. The low levels of serum adiponectin isn’t cause of the metabolic syndrome and insulin resistance, it’s the result of the process that results in metabolic syndrome.
Declarations
Animal and Human Rights Statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Data Availability
The datasets used and/or analyzed during the current study are not publicly available due to patient privacy reasons but are available from the corresponding author on reasonable request.
Conflict of Interest
The authors declare that there is no conflict of interest.
Funding
None.
Additional Information
Publisher’s Note
Bayrakol MP remains neutral with regard to jurisdictional and institutional claims.
Rights and Permissions
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
About This Article
How to Cite This Article
Mustafa Canhoroz, Arzu Canhoroz, Fatih Güzelbulut, Ayşegül Gök Dalbeler, Gül Babacan. The association between serum adiponectin level and glycemic control. J Clin Anal Med 2012;3(2):164-167. doi:10.4328/JCAM.606
Publication History
- Received:
- 12.02.2011
- Accepted:
- 18.03.2011
- Published Online:
- 01.04.2012
- Printed:
- 01.04.2012